FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for the prediction of the early stage of lymphocyte apoptosis. That is ensured by isolating cells, incubating for 48 hours at temperature 37°C with 5% CO2 with adding apoptosis inductor, dexamethasone in the concentration of 10-4 mole/ml. A lymphocyte viability is quantified by trypan blue inclusion, the recovered and oxidised glutathione concentrations are measured in lymphocyte lysate after the 30-minute pre-incubation with 2-vinylpyridine 10 mM. The early stage of lymphocyte apoptosis is stated, if observing an integrated decrease of the recovered glutathione concentration by 17% and more and an increase of the oxidised glutathione concentration by 19% and more as compared to the reference.
EFFECT: using the presented method in medical practice enables predicting the antioxidant state of the patient's body accompanying various diseases as shown by the early stage of lymphocyte apoptosis evaluated.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CELL PROTECTION AGAINST APOPTOSIS | 2013 |
|
RU2541774C2 |
METHOD FOR ASSESSING EFFECTIVENESS OF LYMPHOCYTE PROTECTION AGAINST APOPTOSIS | 2014 |
|
RU2568886C1 |
DIAGNOSTIC TECHNIQUE FOR LYMPHOCYTE APOPTOSIS | 2013 |
|
RU2545900C2 |
METHOD FOR PREDICTION OF EFFECTIVENESS OF LYMPHOCYTE PROTECTION AGAINST PEROXIDATION | 2013 |
|
RU2525183C1 |
METHOD FOR ESTIMATING EFFECTIVENESS OF ANTIOXIDANT ACTIVITY STIMULATION | 2013 |
|
RU2516925C1 |
METHOD FOR SIMULATING LYMPHOCYTE PEROXIDATION | 2013 |
|
RU2541771C2 |
METHOD OF GENETIC TYPING OF POLYMORPHISM rs2551715 OF HUMAN GLUTATHIONE REDUCTASE GENE | 2013 |
|
RU2549688C1 |
ANTIOXIDANT, STRESS AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT SODIUM COMENATE | 2012 |
|
RU2506078C1 |
ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT POTASSIUM COMENATE | 2012 |
|
RU2514632C1 |
AGENT FOR REGULATION OF ENDOGENOUS PRODUCTION OF CYTOKINE AND HEMOPOIETIC FACTOR (VARIANTS) AND METHOD OF ITS USING | 1996 |
|
RU2153351C2 |
Authors
Dates
2015-02-10—Published
2013-05-07—Filed